HIV 1 News and Research

RSS

Detectable blood viral load increases prevalence of heart disease

HIV causes structural heart disease according to research presented at EuroEcho-Imaging 2013 by Dr Nieves Montoro from Madrid, Spain. The findings support the introduction of cardiovascular screening in all HIV patients, particularly those with a positive blood viral load.

11 Dec 2013

Duke University receives $2.9M grant to develop HIV vaccine candidate

Duke University has received a grant of up to $2.9 million from the Bill & Melinda Gates Foundation to produce an HIV vaccine candidate that will be tested in humans.

10 Dec 2013

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

In Zambia, the incidence of all forms of human tuberculosis is estimated to be 444 per 100,000. There is also a high incidence of HIV and AIDS in the country. In the Kafue area, a high incidence of Mycobacterium bovis in both cattle and the Kafue lechwe antilope has been detected. This bacterium can infect humans and has been found in humans in the studied region of Namwala. Mycobacterium tuberculosis, which is the main cause of human tuberculosis, has also been detected in cattle in this region.

10 Dec 2013

IBN and IBM discover new medical application for converted PET bottles

Researchers at Singapore's Institute of Bioengineering and Nanotechnology (IBN) and California's IBM Research - Almaden (IBM) have discovered a new, potentially life-saving application for polyethylene terephthalate (PET), which is widely used to make plastic bottles.

10 Dec 2013

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan Africa.

9 Dec 2013

Revised Clinical Practice Guidelines on management of HCV published by EASL

The European Association for the Study of the Liver today publishes their revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection. The EASL guidelines, which supersede the previous version published in 2011, are designed to help physicians and other healthcare providers optimise their management of patients with acute and chronic HCV.

9 Dec 2013

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.

8 Dec 2013

Longer reads: HIV secrets, millennials' mental health and sleeping pills without side effects

Every week reporter Ankita Rao selects interesting reading from around the Web.

6 Dec 2013

IDSA released new guideline for vaccination of immunocompromised hosts

A new guideline released Thursday by the Infectious Diseases Society of America (IDSA) notes that most people with compromised immune systems are especially vulnerable to illness and should receive the flu shot and other vaccinations.

5 Dec 2013

AAAS Honors Two Tufts University faculty members as Fellows

Two faculty members at Tufts University have been elected Fellows of the American Association for the Advancement of Science (AAAS), an honor bestowed upon AAAS members by their peers. John M. Coffin and planetary scientist Samuel P. Kounaves are among 388 new Fellows recognized by AAAS based on their distinguished efforts to advance science or its applications.

4 Dec 2013

Antiretroviral therapy for HIV treatment saves 2.8 million years of life in South Africa

Antiretroviral therapy for the treatment of HIV infection has saved 2.8 million years of life in South Africa since 2004 and is projected to save an additional 15.1 million years of life by 2030, according to a new study published online in The Journal of Infectious Diseases. The analysis suggests these dramatic benefits could be even greater if more aggressive HIV testing and treatment strategies are implemented.

4 Dec 2013

UCI-led study results have important implications for HIV vaccine development

Infectious disease researchers have identified a novel mechanism wherein HIV-1 may facilitate its own transmission by usurping the antibody response directed against itself. These results have important implications for HIV vaccine development and for understanding the earliest events in HIV transmission.

4 Dec 2013

Older HIV-positive men at higher risk of HPV that causes anal cancer

Human papillomavirus, or HPV, which can cause cervical cancer in women, is also known to cause anal cancer in both women and men. Now, a study led by researchers at the UCLA School of Nursing has found that older HIV-positive men who have sex with men are at higher risk of becoming infected with the HPVs that most often cause anal cancer.

4 Dec 2013

AHF commends donors for rallying to pledge financial support for Global Fund

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today heartily praised donor countries for rallying to pledge financial support for the Global Fund to Fight AIDS, TB, and Malaria.

4 Dec 2013

EU pledges over $500 million to fight AIDS, TB and malaria

The European Union today announced at the Global Fund's Replenishment Conference in Washington, DC, new support of over US $500 million to fight AIDS, tuberculosis and malaria for the 2014-2016 period. The conference takes place just one day after World AIDS Day.

3 Dec 2013

Researchers offer promise of strategy for curing HIV infection

Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering the promise of a strategy for curing HIV infection. Results of the study were presented today at the annual meeting of the Radiological Society of North America (RSNA).

3 Dec 2013

Viewpoints: Where's Obama's 'Mission Accomplished' banner?; health law critics overlooking those denied affordable care in the past

Great news: The White House says that Healthcare.gov and the 36 federally run insurance exchanges are finally good to go. The only thing missing from Sunday's relentlessly upbeat progress report was President Obama in front of a "Mission Accomplished" banner. Sunday's eight-page report was intended to meet Mr. Obama's deadline for fixing the site after its October 1 debut was a calamity. But the more important goal was political -- namely, claiming enough progress to prevent Democrats on Capitol Hill from joining the GOP demand for delaying the individual mandate to buy insurance or even the entire program (12/1).

3 Dec 2013

U.S. Administration to provide $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria

In an address recognizing World AIDS Day, President Barack Obama announced today that the U.S. Administration will commit up to $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria over the next three years. Specifically, he said the United States will contribute $1 for every $2 provided by other donors worldwide through 2016, up to $5 billion.

3 Dec 2013

Newly identified protein could prove promising new drug target for AIDS

Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

2 Dec 2013

GFF launches education campaign to stop violence against women in DRC, prevent HIV/AIDS in military

The Gertler Family Foundation, in partnership with the Armed Forces of the Democratic Republic of the Congo, marked World AIDS Day by launching an aggressive new education campaign to stop violence against women in the DRC and prevent the spread of HIV/AIDS in the military.

2 Dec 2013

HIV 1 News and Research

Detectable blood viral load increases prevalence of heart disease

Duke University receives $2.9M grant to develop HIV vaccine candidate

Study finds large degree of genetic variation amongst M. tuberculosis in humans in Zambia

IBN and IBM discover new medical application for converted PET bottles

Janssen announces first-of-its-kind pediatric HIV treatment donation program

Revised Clinical Practice Guidelines on management of HCV published by EASL

Janssen reports positive pivotal Phase 2 study data of siltuximab for Multicentric Castleman's Disease

Longer reads: HIV secrets, millennials' mental health and sleeping pills without side effects

IDSA released new guideline for vaccination of immunocompromised hosts

AAAS Honors Two Tufts University faculty members as Fellows

Antiretroviral therapy for HIV treatment saves 2.8 million years of life in South Africa

UCI-led study results have important implications for HIV vaccine development

Older HIV-positive men at higher risk of HPV that causes anal cancer

AHF commends donors for rallying to pledge financial support for Global Fund

EU pledges over $500 million to fight AIDS, TB and malaria

Researchers offer promise of strategy for curing HIV infection

Viewpoints: Where's Obama's 'Mission Accomplished' banner?; health law critics overlooking those denied affordable care in the past

U.S. Administration to provide $5 billion to the Global Fund to Fight AIDS, Tuberculosis and Malaria

Newly identified protein could prove promising new drug target for AIDS

GFF launches education campaign to stop violence against women in DRC, prevent HIV/AIDS in military

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News